WallStreetZenWallStreetZen

NASDAQ: MDXG
Mimedx Group Inc Stock

$3.54+0.10 (+2.91%)
Updated Mar 23, 2023
MDXG Price
$3.54
Fair Value Price
$4.12
Market Cap
$403.85M
52 Week Low
$2.43
52 Week High
$5.06
P/E
-10.73x
P/B
-22.45x
P/S
1.17x
PEG
N/A
Dividend Yield
N/A
Revenue
$267.84M
Earnings
-$36.78M
Gross Margin
82%
Operating Margin
-11.78%
Profit Margin
-13.7%
Debt to Equity
-5.39
Operating Cash Flow
-$18M
Beta
2.18
Next Earnings
May 1, 2023
Ex-Dividend
N/A
Next Dividend
N/A

MDXG Overview

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a semi-permeable protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications; and AMNIOBURN a semi-permeable protective barrier allograft used in the treatment of partial-thickness and full-thickness burns, as well as lead product includes mdHACM, a micronized form of AMNIOFIX, supplied in powder form. The company's products have applications primarily in the areas of wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. It also sells allografts for dental applications on an original equipment manufacturer basis. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. is headquartered in Marietta, Georgia.

Zen Score

Industry Average (31)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MDXG scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MDXG ($3.54) is undervalued by 14.08% relative to our estimate of its Fair Value price of $4.12 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
MDXG ($3.54) is not significantly undervalued (14.08%) relative to our estimate of its Fair Value price of $4.12 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
MDXG is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more MDXG due diligence checks available for Premium users.

Be the first to know about important MDXG news, forecast changes, insider trades & much more!

MDXG News

Valuation

MDXG fair value

Fair Value of MDXG stock based on Discounted Cash Flow (DCF)
Price
$3.54
Fair Value
$4.12
Undervalued by
14.08%
MDXG ($3.54) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MDXG ($3.54) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MDXG is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

MDXG price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-10.73x
Industry
87.68x
Market
21.14x

MDXG price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-22.45x
Industry
3.73x

MDXG's financial health

Profit margin

Revenue
$74.4M
Net Income
-$2.1M
Profit Margin
-2.8%
MDXG's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
MDXG's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$171.4M
Liabilities
$96.9M
Debt to equity
-5.39
MDXG's short-term assets ($134.20M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MDXG's short-term assets ($134.20M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MDXG's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MDXG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$5.6M
Investing
-$1.7M
Financing
$66.0k
MDXG's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

MDXG vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
MDXG$403.85M+2.91%-10.73x-22.45x
QTRX$398.93M-0.56%-4.10x1.11x
APEN$412.18M+0.10%-9.43x9.74x
BFLY$394.67M+1.04%-2.31x1.21x
ZYXI$390.89M-0.93%24.25x5.89x

Mimedx Group Stock FAQ

What is Mimedx Group's quote symbol?

NASDAQ: MDXG) Mimedx Group trades on the NASDAQ under the ticker symbol MDXG. Mimedx Group stock quotes can also be displayed as NASDAQ: MDXG.

If you're new to stock investing, here's how to buy Mimedx Group stock.

What is the 52 week high and low for Mimedx Group (NASDAQ: MDXG)?

(NASDAQ: MDXG) Mimedx Group's 52-week high was $5.06, and its 52-week low was $2.43. It is currently -29.97% from its 52-week high and 45.68% from its 52-week low.

How much is Mimedx Group stock worth today?

(NASDAQ: MDXG) Mimedx Group currently has 114,083,096 outstanding shares. With Mimedx Group stock trading at $3.54 per share, the total value of Mimedx Group stock (market capitalization) is $403.85M.

Mimedx Group stock was originally listed at a price of $4.63 in Feb 12, 2008. If you had invested in Mimedx Group stock at $4.63, your return over the last 15 years would have been -23.54%, for an annualized return of -1.77% (not including any dividends or dividend reinvestments).

How much is Mimedx Group's stock price per share?

(NASDAQ: MDXG) Mimedx Group stock price per share is $3.54 today (as of Mar 23, 2023).

What is Mimedx Group's Market Cap?

(NASDAQ: MDXG) Mimedx Group's market cap is $403.85M, as of Mar 24, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Mimedx Group's market cap is calculated by multiplying MDXG's current stock price of $3.54 by MDXG's total outstanding shares of 114,083,096.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.